PMID: 6710428Mar 1, 1984Paper

Serum amyloid A protein and C-reactive protein levels in pulmonary tuberculosis: relationship to amyloidosis

Thorax
F C de BeerA F Strachan

Abstract

C-reactive protein and serum amyloid A protein levels were measured in 54 patients with pulmonary tuberculosis. The primary tuberculous complex was associated with an insignificant acute phase response, while post-primary tuberculosis without evidence of lung destruction caused modest increases in C-reactive protein and serum amyloid A protein. In most patients with post-primary pulmonary tuberculosis with significant pulmonary destruction there was a major acute phase response, with very high serum amyloid A protein and C-reactive protein levels. The response in these patients is most likely to be due to secondary bacterial infection in addition to infection by Mycobacterium tuberculosis. Patients with miliary tuberculosis showed a major acute phase response. Serum amyloid A protein and C-reactive protein levels decreased rapidly after initiation of treatment in the patients with post-primary tuberculosis without significant pulmonary destruction.

References

Sep 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·E P Benditt, N Eriksen
Oct 1, 1978·The Journal of Experimental Medicine·G LavieE C Franklin
Mar 21, 1981·Lancet·M B Pepys
Jun 12, 1980·The New England Journal of Medicine·G G Glenner
Jan 1, 1982·Journal of Immunological Methods·F C De Beer, M B Pepys
Nov 25, 1981·Clinica Chimica Acta; International Journal of Clinical Chemistry·B ShineM B Pepys
Nov 1, 1955·A.M.A. Archives of Internal Medicine·R J ROANTREE, L A RANTZ

❮ Previous
Next ❯

Citations

Jan 26, 2013·Epidemiologic Reviews·Francis Mawanda, Robert Wallace
Jan 1, 1991·Journal of Gastroenterology and Hepatology·J DentS J Spechler
Jan 1, 2009·BMJ Case Reports·Madhav BansalRakesh Biswas
Apr 6, 1985·British Medical Journal·G M Cochrane
Nov 17, 2009·American Journal of Respiratory and Critical Care Medicine·Edward S ChenDavid R Moller
Jan 21, 2011·PloS One·Dongwan D KangShabaana A Khader
Oct 27, 2004·The Tohoku Journal of Experimental Medicine·Suna BüyüköztürkBahattin Colakoglu
Feb 28, 2003·FEBS Letters·Urban A KiernanRandall W Nelson
Aug 25, 2004·Medical Hypotheses·L Broxmeyer
Nov 26, 2015·Clinics in Chest Medicine·Lindsay J CeladaWonder P Drake
Jul 13, 1988·Diabetes Research and Clinical Practice·S F van EedenS F Hough
Jun 22, 2005·Medical Hypotheses·Lawrence Broxmeyer
May 30, 2015·Tuberculosis·A JayakumarUNKNOWN Tuberculosis Trials Consortium
Aug 22, 2006·International Immunopharmacology·Ferhan OzsekerHalim Issever
Jun 27, 2020·JAD Reports·Bo NiklassonElisabet Englund
May 1, 1993·Annals of Clinical Biochemistry·M T CaslN Jagarinec

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.